Lung function trajectories in patients with idiopathic pulmonary fibrosis
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterised by decline in lung function. We evaluated trajectories of forced vital capacity (FVC) and diffusing capacity (DLco) in a cohort of patients with IPF. Methods Patients with IPF t...
Main Authors: | Megan L Neely, Anne S Hellkamp, Shaun Bender, Jamie L Todd, Timothy Liesching, Tracy R Luckhardt, Justin M Oldham, Rishi Raj, Eric S White, Scott M Palmer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-023-02503-5 |
Similar Items
-
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
by: Luca Richeldi, et al.
Published: (2020-01-01) -
Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
by: Justin M. Oldham, et al.
Published: (2017-08-01) -
Hospitalizations in patients with idiopathic pulmonary fibrosis
by: Hyun J. Kim, et al.
Published: (2021-09-01) -
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
by: Francesco Amati, et al.
Published: (2023-04-01) -
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
by: Ross Summer, et al.
Published: (2024-01-01)